Zkusit zdarma
Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

HALO
Cena:
$ 68.32
-0.20 (-0.29%)
Valuace
48
Růst
60
Zdraví
63
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Halozyme Therapeutics: Royalty King

Halozyme Therapeutics: Royalty King

22:33 19-05-2026

Halozyme Therapeutics is delivering strong shareholder value, driven by robust royalty growth and di...

Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial

Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial

8:30 19-05-2026

Acquisition gives Nexalin control of AI-integrated remote patient-monitoring, clinical data-capture ...

One of the market's hottest stock themes is buying everything AI can't replace

One of the market's hottest stock themes is buying everything AI can't replace

10:21 17-05-2026

Josh Brown, co-founder and CEO of Ritholtz Wealth Management, coined the term HALO as a way to ident...

Roundhill launches

Roundhill launches "HALO" ETF

16:51 14-05-2026

Dave Mazza, CEO of Roundhill Investments, joins CNBC's "Halftime Report" to highlight the launch of ...

Halozyme's Q1 Earnings & Revenues Beat Estimates, Stock Up

Halozyme's Q1 Earnings & Revenues Beat Estimates, Stock Up

12:51 12-05-2026

HALO beats Q1 earnings estimates as royalty revenues from partner drugs and strong product sales lif...

Halozyme Therapeutics, Inc. (HALO) Q1 2026 Earnings Call Transcript

Halozyme Therapeutics, Inc. (HALO) Q1 2026 Earnings Call Transcript

22:50 11-05-2026

Halozyme Therapeutics, Inc. (HALO) Q1 2026 Earnings Call Transcript...

Halozyme Therapeutics Q1 Earnings Call Highlights

Halozyme Therapeutics Q1 Earnings Call Highlights

20:09 11-05-2026

Halozyme Therapeutics NASDAQ: HALO reported a sharp increase in first-quarter 2026 revenue and earni...

Halozyme Therapeutics (HALO) Reports Q1 Earnings: What Key Metrics Have to Say

Halozyme Therapeutics (HALO) Reports Q1 Earnings: What Key Metrics Have to Say

18:31 11-05-2026

While the top- and bottom-line numbers for Halozyme Therapeutics (HALO) give a sense of how the busi...

Halozyme Therapeutics (HALO) Surpasses Q1 Earnings and Revenue Estimates

Halozyme Therapeutics (HALO) Surpasses Q1 Earnings and Revenue Estimates

18:16 11-05-2026

Halozyme Therapeutics (HALO) came out with quarterly earnings of $1.6 per share, beating the Zacks C...

HALOZYME REPORTS FIRST QUARTER 2026 RESULTS AND REITERATES 2026 FINANCIAL GUIDANCE

HALOZYME REPORTS FIRST QUARTER 2026 RESULTS AND REITERATES 2026 FINANCIAL GUIDANCE

16:01 11-05-2026

Announcing New $1 billion Share Repurchase Program Projecting to Buy Back at Least $400 million in 2...

Meet The Nvidia HALO Trade: 6 Stocks That May Rise Every Time Jensen Huang Scales AI

Meet The Nvidia HALO Trade: 6 Stocks That May Rise Every Time Jensen Huang Scales AI

12:54 07-05-2026

Nvidia Corp (NASDAQ:NVDA) may still be the center of the AI trade. But Wall Street is increasingly s...

Halozyme Therapeutics (HALO) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Halozyme Therapeutics (HALO) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

10:15 06-05-2026

Besides Wall Street's top-and-bottom-line estimates for Halozyme Therapeutics (HALO), review project...

Halozyme Therapeutics: The Royalty Engine Is Becoming A Drug-Delivery Toll Road

Halozyme Therapeutics: The Royalty Engine Is Becoming A Drug-Delivery Toll Road

0:54 06-05-2026

Halozyme (HALO) is evolving from an ENHANZE royalty story into a diversified subcutaneous drug deliv...

Halozyme to Report First Quarter 2026 Financial and Operating Results

Halozyme to Report First Quarter 2026 Financial and Operating Results

16:30 30-04-2026

SAN DIEGO, April 30, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme") to...

Halozyme Appoints Darren Snellgrove as Chief Financial Officer

Halozyme Appoints Darren Snellgrove as Chief Financial Officer

8:00 30-04-2026

SAN DIEGO, April 30, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or...

Halozyme Therapeutics (HALO) Earnings Expected to Grow: What to Know Ahead of Q1 Release

Halozyme Therapeutics (HALO) Earnings Expected to Grow: What to Know Ahead of Q1 Release

11:08 28-04-2026

Halozyme Therapeutics (HALO) doesn't possess the right combination of the two key ingredients for a ...

Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment

Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment

9:35 22-04-2026

160-participant, triple-blinded, sham-controlled study designed to support planned De Novo FDA submi...

Goldman's HALO Trade Could Be the 2026 Edge Investors Are Missing

Goldman's HALO Trade Could Be the 2026 Edge Investors Are Missing

10:11 10-04-2026

Goldman Sachs (NYSE:GS) has a pretty interesting strategy for investors who aren't yet comfortable b...

Helen Torley Sells 10,000 Shares of Halozyme Therapeutics (NASDAQ:HALO) Stock

Helen Torley Sells 10,000 Shares of Halozyme Therapeutics (NASDAQ:HALO) Stock

4:02 09-04-2026

Halozyme Therapeutics, Inc. (NASDAQ: HALO - Get Free Report) CEO Helen Torley sold 10,000 shares of ...

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Recommendation of “Hold” by Brokerages

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Recommendation of “Hold” by Brokerages

2:15 08-04-2026

Shares of Halozyme Therapeutics, Inc. (NASDAQ: HALO - Get Free Report) have earned an average recomm...

close

HALOZYME TO REPORT FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL AND OPERATING RESULTS

10-02-2026
SAN DIEGO, FEB. 10, 2026 /PRNEWSWIRE/ -- HALOZYME THERAPEUTICS, INC. (NASDAQ: HALO) ("HALOZYME") TOD...
Více zde

HALOZYME RAISES 2025 REVENUE ESTIMATES, RAISES 2026 AND MULTI-YEAR FINANCIAL GUIDANCE

28-01-2026
UPDATES PRELIMINARY UNAUDITED 2025 ESTIMATES: - TOTAL REVENUE OF  $1,385 - $1,400 MILLION, YOY GROW...
Více zde

CLEANTEK INDUSTRIES SECURES SIGNIFICANT INTERNATIONAL HALO SE CROWN MOUNT CONTRACT

22-01-2026
CALGARY, ALBERTA--(NEWSFILE CORP. - JANUARY 22, 2026) - CLEANTEK INDUSTRIES INC. (TSXV: CTEK) ("CLEA...
Více zde

HALOZYME TO HOST INVESTOR CONFERENCE CALL TO PROVIDE UPDATED FINANCIAL GUIDANCE AND BUSINESS UPDATE

20-01-2026
SAN DIEGO, JAN. 20, 2026 /PRNEWSWIRE/ -- HALOZYME THERAPEUTICS, INC. (NASDAQ: HALO) ("HALOZYME") TOD...
Více zde

HALOZYME ANNOUNCES GLOBAL COLLABORATION AND LICENSE AGREEMENT WITH TAKEDA TO DEVELOP AND COMMERCIALIZE VEDOLIZUMAB WITH ENHANZE®

08-01-2026
AGREEMENT PROVIDES TAKEDA WITH EXCLUSIVE ACCESS TO ENHANZE® DRUG DELIVERY TECHNOLOGY FOR VEDOLIZUMA...
Více zde

HALOZYME AND SKYE BIOSCIENCE ANNOUNCE GLOBAL COLLABORATION AND LICENSE AGREEMENT TO EVALUATE NIMACIMAB CO-FORMULATED WITH ENHANZE® FOR OBESITY

05-01-2026
AGREEMENT SUPPORTS DEVELOPMENT AND COMMERCIALIZATION OF HIGHER-DOSE, SUBCUTANEOUS ADMINISTRATION STR...
Více zde

U.S. FDA APPROVES RYBREVANT FASPRO™ (AMIVANTAMAB AND HYALURONIDASE-LPUJ) CO-FORMULATED WITH ENHANZE® FOR THE TREATMENT OF ADVANCED EGFR-MUTATED NON-SMALL CELL LUNG CANCER

18-12-2025
RYBREVANT FASPRO™ IS APPROVED ACROSS ALL INDICATIONS OF RYBREVANT® (AMIVANTAMAB-VMJW) SAN DIEGO ,...
Více zde

JIM LANG ELECTED TO HALOZYME'S BOARD OF DIRECTORS

08-12-2025
SAN DIEGO , DEC. 8, 2025 /PRNEWSWIRE/ -- HALOZYME THERAPEUTICS, INC. (NASDAQ:  HALO ) ("HALOZYME") ...
Více zde

HALOZYME WINS PRELIMINARY INJUNCTION AGAINST MERCK'S KEYTRUDA SC IN GERMANY

04-12-2025
SAN DIEGO , DEC. 4, 2025 /PRNEWSWIRE/ -- HALOZYME THERAPEUTICS, INC. (NASDAQ: HALO) (HALOZYME), ANN...
Více zde

HALOZYME TO PARTICIPATE IN THE 8TH ANNUAL EVERCORE HEALTHCARE CONFERENCE

25-11-2025
SAN DIEGO , NOV. 25, 2025 /PRNEWSWIRE/ -- HALOZYME THERAPEUTICS, INC. (NASDAQ: HALO) ("HALOZYME") T...
Více zde

HALOZYME COMPLETES ACQUISITION OF ELEKTROFI, EXPANDING BREADTH OF OFFERINGS IN DRUG DELIVERY

18-11-2025
ROYALTY REVENUE CONTRIBUTION EXPECTED TO BEGIN AS EARLY AS 2030 INITIAL PARTNER TARGETS INCLUDE DERI...
Více zde

MERUS AND HALOZYME ENTER GLOBAL COLLABORATION AND LICENSE AGREEMENT TO DEVELOP SUBCUTANEOUS FORMULATION OF PETOSEMTAMAB

17-11-2025
SAN DIEGO AND UTRECHT, THE NETHERLANDS AND CAMBRIDGE, MASS. , NOV. 17, 2025 /PRNEWSWIRE/ -- MERUS N....
Více zde

FDA APPROVED DARZALEX FASPRO® FOR ADULT PATIENTS WITH HIGH-RISK SMOLDERING MULTIPLE MYELOMA

07-11-2025
DARZALEX FASPRO® IS CO-FORMULATED WITH HALOZYME'S ENHANZE® DRUG DELIVERY TECHNOLOGY SAN DIEGO , NO...
Více zde

HALOZYME THERAPEUTICS, INC. ANNOUNCES PRICING OF PRIVATE OFFERING OF $650 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2031 AND $650 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2032

06-11-2025
SAN DIEGO , NOV. 6, 2025 /PRNEWSWIRE/ -- HALOZYME THERAPEUTICS, INC. (NASDAQ: HALO) ("HALOZYME" OR T...
Více zde

HALOZYME THERAPEUTICS, INC. ANNOUNCES PROPOSED OFFERING OF $650 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2031 AND $650 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2032

05-11-2025
SAN DIEGO , NOV. 5, 2025 /PRNEWSWIRE/ -- HALOZYME THERAPEUTICS, INC. (NASDAQ: HALO) ("HALOZYME" OR T...
Více zde

HALOZYME RAISES 2025 FINANCIAL GUIDANCE AND REPORTS STRONG THIRD QUARTER 2025 FINANCIAL AND OPERATING RESULTS

03-11-2025
ROYALTY REVENUE INCREASED 52% YOY TO RECORD $236 MILLION AND TOTAL REVENUE INCREASED 22% YOY TO REC...
Více zde

HALOZYME TO REPORT THIRD QUARTER 2025 FINANCIAL AND OPERATING RESULTS

21-10-2025
SAN DIEGO , OCT. 21, 2025 /PRNEWSWIRE/ -- HALOZYME THERAPEUTICS, INC. (NASDAQ: HALO) ("HALOZYME") TO...
Více zde

HALOZYME TO ACQUIRE ELEKTROFI, EXPANDING OUR OFFERINGS IN INNOVATIVE DRUG DELIVERY AND STRENGTHENING LONG-TERM GROWTH INTO 2040S

01-10-2025
ROYALTY REVENUE CONTRIBUTION EXPECTED TO BEGIN AS EARLY AS 2030 INITIAL PARTNER TARGETS INCLUDE DERI...
Více zde

NEXALIN TECHNOLOGY ANNOUNCES ISSUANCE OF U.S. PATENT COVERING HALO™ CLARITY DEVICE FEATURING DIFS™ TECHNOLOGY

25-09-2025
HOUSTON, TX, SEPT. 25, 2025 (GLOBE NEWSWIRE) -- NEXALIN TECHNOLOGY, INC. (NASDAQ: NXL; NXLIW) (THE ...
Více zde

HALOZYME TO PARTICIPATE AT UPCOMING INVESTOR CONFERENCES

28-08-2025
SAN DIEGO , AUG. 28, 2025 /PRNEWSWIRE/ -- HALOZYME THERAPEUTICS, INC. (NASDAQ: HALO) ("HALOZYME") TO...
Více zde

HALOZYME RAISES 2025 FINANCIAL GUIDANCE RANGES AND REPORTS STRONG SECOND QUARTER 2025 RESULTS

05-08-2025
TOTAL REVENUE INCREASED 41% YOY TO $326 MILLION AND ROYALTY REVENUE INCREASED 65% YOY TO $206 MILLIO...
Více zde

EUROPEAN COMMISSION APPROVED DARZALEX FASPRO® FOR ADULT PATIENTS WITH SMOULDERING MULTIPLE MYELOMA

23-07-2025
DARZALEX FASPRO® IS CO-FORMULATED WITH HALOZYME'S ENHANZE® DRUG DELIVERY TECHNOLOGY APPROVAL REPRE...
Více zde

HALOZYME TO REPORT SECOND QUARTER 2025 FINANCIAL AND OPERATING RESULTS

22-07-2025
SAN DIEGO , JULY 22, 2025 /PRNEWSWIRE/ -- HALOZYME THERAPEUTICS, INC. (NASDAQ: HALO) ("HALOZYME") TO...
Více zde

HALOZYME THERAPEUTICS ADDED TO RUSSELL 1000® INDEX

30-06-2025
SAN DIEGO , JUNE 30, 2025 /PRNEWSWIRE/ -- HALOZYME THERAPEUTICS, INC. (NASDAQ: HALO) (HALOZYME) TODA...
Více zde

HALOZYME ANNOUNCES ARGENX RECEIVED EUROPEAN COMMISSION APPROVAL FOR VYVGART® SUBCUTANEOUS INJECTION WITH ENHANZE® FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)

20-06-2025
SC INJECTION OF VYVGART® IS AVAILABLE AS A VIAL OR PREFILLED SYRINGE AND CAN BE ADMINISTERED BY A P...
Více zde

HALOZYME TO PARTICIPATE AT UPCOMING INVESTOR CONFERENCES

28-05-2025
SAN DIEGO , MAY 28, 2025 /PRNEWSWIRE/ -- HALOZYME THERAPEUTICS, INC. (NASDAQ: HALO) ("HALOZYME") TOD...
Více zde

HALOZYME ANNOUNCES BRISTOL MYERS SQUIBB RECEIVED EUROPEAN COMMISSION APPROVAL FOR SUBCUTANEOUS OPDIVO® (NIVOLUMAB) CO-FORMULATED WITH ENHANZE® ACROSS MULTIPLE SOLID TUMOR INDICATIONS

28-05-2025
OPDIVO® IS THE FIRST AND ONLY PD-1 INHIBITOR APPROVED FOR SUBCUTANEOUS (SC) USE IN THE EUROPEAN UNI...
Více zde

HALOZYME RAISES 2025 FINANCIAL GUIDANCE RANGES AND REPORTS STRONG FIRST QUARTER 2025 RESULTS

06-05-2025
ANNOUNCING NEW $250M SHARE REPURCHASE  TOTAL REVENUE INCREASED 35% YOY TO $265 MILLION AND ROYALTY ...
Více zde

HALOZYME TO PARTICIPATE IN THE BOFA SECURITIES 2025 HEALTHCARE CONFERENCE

05-05-2025
SAN DIEGO , MAY 5, 2025 /PRNEWSWIRE/ -- HALOZYME THERAPEUTICS, INC. (NASDAQ: HALO) ("HALOZYME") TODA...
Více zde

HALOZYME TO REPORT FIRST QUARTER 2025 FINANCIAL AND OPERATING RESULTS

28-04-2025
SAN DIEGO , APRIL 28, 2025 /PRNEWSWIRE/ -- HALOZYME THERAPEUTICS, INC. (NASDAQ: HALO) ("HALOZYME") ...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-28 00:00:008-KStáhnout
2025-12-09 00:00:008-KStáhnout
2025-12-08 00:00:008-KStáhnout
2025-11-24 00:00:008-KStáhnout
2025-11-12 00:00:008-KStáhnout
2025-11-07 00:00:008-KStáhnout
2025-11-05 00:00:008-KStáhnout
2025-11-03 00:00:008-KStáhnout
2025-11-03 00:00:0010-QStáhnout
2025-10-14 01:00:008-KStáhnout
2025-10-14 00:00:008-KStáhnout
2025-10-06 01:00:008-KStáhnout
2025-10-06 00:00:008-KStáhnout
2025-10-03 01:00:008-KStáhnout
2025-10-03 00:00:008-KStáhnout
2025-10-01 01:00:008-KStáhnout
2025-10-01 00:00:008-KStáhnout
2025-08-05 01:00:008-KStáhnout
2025-08-05 01:00:0010-QStáhnout
2025-08-05 00:00:008-KStáhnout
2025-08-05 00:00:0010-QStáhnout
2025-05-06 01:00:008-KStáhnout
2025-05-06 01:00:0010-QStáhnout
2025-05-06 00:00:008-KStáhnout
2025-05-06 00:00:0010-QStáhnout
2025-05-02 01:00:008-KStáhnout
2025-05-02 00:00:008-KStáhnout
2025-03-21 00:00:008-KStáhnout
2025-03-20 23:00:008-KStáhnout
2025-02-18 00:00:008-KStáhnout
2025-02-18 00:00:0010-KStáhnout
2025-02-17 23:00:008-KStáhnout
2025-02-17 23:00:0010-KStáhnout
2025-02-13 00:00:008-KStáhnout
2025-02-12 23:00:008-KStáhnout
2025-01-08 00:00:008-KStáhnout
2025-01-07 23:00:008-KStáhnout
2024-10-31 00:00:008-KStáhnout
2024-10-31 00:00:0010-QStáhnout
2024-10-30 23:00:008-KStáhnout
2024-10-30 23:00:0010-QStáhnout
2024-08-06 01:00:008-KStáhnout
2024-08-06 01:00:0010-QStáhnout
2024-08-06 00:00:008-KStáhnout
2024-08-06 00:00:0010-QStáhnout
2024-05-07 01:00:008-KStáhnout
2024-05-07 01:00:0010-QStáhnout
2024-05-07 00:00:008-KStáhnout
2024-05-07 00:00:0010-QStáhnout
2024-04-26 01:00:008-KStáhnout
2024-04-26 00:00:008-KStáhnout
2024-02-20 00:00:008-KStáhnout
2024-02-20 00:00:0010-KStáhnout
2024-02-19 23:00:008-KStáhnout
2024-02-19 23:00:0010-KStáhnout
2024-01-17 00:00:008-KStáhnout
2024-01-16 23:00:008-KStáhnout
2023-11-06 00:00:008-KStáhnout
2023-11-06 00:00:0010-QStáhnout
2023-11-05 23:00:008-KStáhnout
2023-11-05 23:00:0010-QStáhnout
2023-09-07 01:00:008-KStáhnout
2023-09-07 00:00:008-KStáhnout
2023-08-08 01:00:008-KStáhnout
2023-08-08 01:00:0010-QStáhnout
2023-08-08 00:00:008-KStáhnout
2023-08-08 00:00:0010-QStáhnout
2023-05-09 01:00:008-KStáhnout
2023-05-09 01:00:0010-QStáhnout
2023-05-09 00:00:008-KStáhnout
2023-05-09 00:00:0010-QStáhnout
2023-05-08 01:00:008-KStáhnout
2023-05-08 00:00:008-KStáhnout
2023-03-16 00:00:008-KStáhnout
2023-03-15 23:00:008-KStáhnout
2023-03-13 00:00:008-KStáhnout
2023-03-12 23:00:008-KStáhnout
2023-02-23 00:00:008-KStáhnout
2023-02-22 23:00:008-KStáhnout
2023-02-21 00:00:008-KStáhnout
2023-02-21 00:00:0010-KStáhnout
2023-02-20 23:00:008-KStáhnout
2023-02-20 23:00:0010-KStáhnout
2023-02-06 00:00:008-KStáhnout
2023-02-05 23:00:008-KStáhnout
2023-01-10 00:00:008-KStáhnout
2023-01-09 23:00:008-KStáhnout
2022-11-08 00:00:008-KStáhnout
2022-11-08 00:00:0010-QStáhnout
2022-11-07 23:00:008-KStáhnout
2022-11-07 23:00:0010-QStáhnout
2022-08-19 01:00:008-KStáhnout
2022-08-19 00:00:008-KStáhnout
2022-08-18 01:00:008-KStáhnout
2022-08-18 00:00:008-KStáhnout
2022-08-16 01:00:008-KStáhnout
2022-08-16 00:00:008-KStáhnout
2022-08-15 01:00:008-KStáhnout
2022-08-15 00:00:008-KStáhnout
2022-08-09 01:00:008-KStáhnout
2022-08-09 01:00:0010-QStáhnout
2022-08-09 00:00:008-KStáhnout
2022-08-09 00:00:0010-QStáhnout
2022-05-24 01:00:008-KStáhnout
2022-05-24 00:00:008-KStáhnout
2022-05-10 01:00:008-KStáhnout
2022-05-10 01:00:0010-QStáhnout
2022-05-10 00:00:008-KStáhnout
2022-05-10 00:00:0010-QStáhnout
2022-05-06 01:00:008-KStáhnout
2022-05-06 00:00:008-KStáhnout
2022-04-13 01:00:008-KStáhnout
2022-04-13 00:00:008-KStáhnout
2022-03-21 00:00:008-KStáhnout
2022-03-20 23:00:008-KStáhnout
2022-03-15 00:00:008-KStáhnout
2022-03-14 23:00:008-KStáhnout
2022-02-22 00:00:008-KStáhnout
2022-02-22 00:00:0010-KStáhnout
2022-02-21 23:00:008-KStáhnout
2022-02-21 23:00:0010-KStáhnout
2022-02-03 00:00:008-KStáhnout
2022-02-02 23:00:008-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2021-12-29 00:00:008-KStáhnout
2021-12-28 23:00:008-KStáhnout
2021-12-13 00:00:008-KStáhnout
2021-12-12 23:00:008-KStáhnout
2021-12-10 00:00:008-KStáhnout
2021-12-09 23:00:008-KStáhnout
2021-11-02 00:00:008-KStáhnout
2021-11-02 00:00:0010-QStáhnout
2021-11-01 23:00:008-KStáhnout
2021-11-01 23:00:0010-QStáhnout
2021-08-09 01:00:008-KStáhnout
2021-08-09 01:00:0010-QStáhnout
2021-08-09 00:00:008-KStáhnout
2021-08-09 00:00:0010-QStáhnout
2021-05-10 01:00:008-KStáhnout
2021-05-10 01:00:0010-QStáhnout
2021-05-10 00:00:008-KStáhnout
2021-05-10 00:00:0010-QStáhnout
2021-05-07 01:00:008-KStáhnout
2021-05-07 00:00:008-KStáhnout
2021-05-05 01:00:008-KStáhnout
2021-05-05 00:00:008-KStáhnout
2021-05-03 01:00:008-KStáhnout
2021-05-03 00:00:008-KStáhnout
2021-03-01 00:00:008-KStáhnout
2021-02-28 23:00:008-KStáhnout
2021-02-25 00:00:008-KStáhnout
2021-02-24 23:00:008-KStáhnout
2021-02-23 00:00:008-KStáhnout
2021-02-23 00:00:0010-KStáhnout
2021-02-22 23:00:008-KStáhnout
2021-02-22 23:00:0010-KStáhnout
2021-01-13 00:00:008-KStáhnout
2021-01-12 23:00:008-KStáhnout
2021-01-11 00:00:008-KStáhnout
2021-01-10 23:00:008-KStáhnout
2020-11-02 00:00:008-KStáhnout
2020-11-02 00:00:0010-QStáhnout
2020-11-01 23:00:008-KStáhnout
2020-11-01 23:00:0010-QStáhnout
2020-08-10 01:00:008-KStáhnout
2020-08-10 01:00:0010-QStáhnout
2020-08-10 00:00:008-KStáhnout
2020-08-10 00:00:0010-QStáhnout
2020-05-11 01:00:008-KStáhnout
2020-05-11 01:00:0010-QStáhnout
2020-05-11 00:00:008-KStáhnout
2020-05-11 00:00:0010-QStáhnout
2020-05-04 01:00:008-KStáhnout
2020-05-04 00:00:008-KStáhnout
2020-02-24 00:00:008-KStáhnout
2020-02-24 00:00:0010-KStáhnout
2020-02-23 23:00:008-KStáhnout
2020-02-23 23:00:0010-KStáhnout
2020-01-16 00:00:008-KStáhnout
2020-01-15 23:00:008-KStáhnout
2020-01-14 00:00:008-KStáhnout
2020-01-13 23:00:008-KStáhnout
2019-11-18 00:00:008-KStáhnout
2019-11-17 23:00:008-KStáhnout
2019-11-14 00:00:008-KStáhnout
2019-11-13 23:00:008-KStáhnout
2019-11-12 00:00:008-KStáhnout
2019-11-12 00:00:0010-QStáhnout
2019-11-11 23:00:008-KStáhnout
2019-11-11 23:00:0010-QStáhnout
2019-11-05 00:00:008-KStáhnout
2019-11-04 23:00:008-KStáhnout
2019-09-04 01:00:008-KStáhnout
2019-09-04 00:00:008-KStáhnout
2019-08-06 01:00:008-KStáhnout
2019-08-06 01:00:0010-QStáhnout
2019-08-06 00:00:008-KStáhnout
2019-08-06 00:00:0010-QStáhnout
2019-06-12 01:00:008-KStáhnout
2019-06-12 00:00:008-KStáhnout
2019-05-07 01:00:008-KStáhnout
2019-05-07 01:00:0010-QStáhnout
2019-05-07 00:00:008-KStáhnout
2019-05-07 00:00:0010-QStáhnout
2019-05-03 01:00:008-KStáhnout
2019-05-03 00:00:008-KStáhnout
2019-02-21 00:00:008-KStáhnout
2019-02-21 00:00:0010-KStáhnout
2019-02-20 23:00:008-KStáhnout
2019-02-20 23:00:0010-KStáhnout
2019-01-09 00:00:008-KStáhnout
2019-01-08 23:00:008-KStáhnout
2018-12-13 00:00:008-KStáhnout
2018-12-12 23:00:008-KStáhnout
2018-11-26 00:00:008-KStáhnout
2018-11-25 23:00:008-KStáhnout
2018-11-06 00:00:008-KStáhnout
2018-11-06 00:00:0010-QStáhnout
2018-11-05 23:00:008-KStáhnout
2018-11-05 23:00:0010-QStáhnout
2018-09-10 01:00:008-KStáhnout
2018-09-10 00:00:008-KStáhnout
2018-09-05 01:00:008-KStáhnout
2018-09-05 00:00:008-KStáhnout
2018-08-07 01:00:008-KStáhnout
2018-08-07 01:00:0010-QStáhnout
2018-08-07 00:00:008-KStáhnout
2018-08-07 00:00:0010-QStáhnout
2018-05-10 01:00:008-KStáhnout
2018-05-10 01:00:0010-QStáhnout
2018-05-10 00:00:008-KStáhnout
2018-05-10 00:00:0010-QStáhnout
2018-05-02 01:00:008-KStáhnout
2018-05-02 00:00:008-KStáhnout
2018-04-06 01:00:008-KStáhnout
2018-04-06 00:00:008-KStáhnout
2018-03-22 00:00:008-KStáhnout
2018-03-21 23:00:008-KStáhnout
2018-02-20 00:00:008-KStáhnout
2018-02-20 00:00:0010-KStáhnout
2018-02-19 23:00:008-KStáhnout
2018-02-19 23:00:0010-KStáhnout
2018-01-12 00:00:008-KStáhnout
2018-01-11 23:00:008-KStáhnout
2018-01-10 00:00:008-KStáhnout
2018-01-09 23:00:008-KStáhnout
2017-11-07 00:00:008-KStáhnout
2017-11-07 00:00:0010-QStáhnout
2017-11-06 23:00:008-KStáhnout
2017-11-06 23:00:0010-QStáhnout
2017-09-29 01:00:008-KStáhnout
2017-09-29 00:00:008-KStáhnout
2017-08-08 01:00:008-KStáhnout
2017-08-08 01:00:0010-QStáhnout
2017-08-08 00:00:008-KStáhnout
2017-08-08 00:00:0010-QStáhnout
2017-07-05 01:00:008-KStáhnout
2017-07-05 00:00:008-KStáhnout
2017-05-19 01:00:008-KStáhnout
2017-05-19 00:00:008-KStáhnout
2017-05-09 01:00:008-KStáhnout
2017-05-09 01:00:0010-QStáhnout
2017-05-09 00:00:008-KStáhnout
2017-05-09 00:00:0010-QStáhnout
2017-05-05 01:00:008-KStáhnout
2017-05-05 00:00:008-KStáhnout
2017-02-28 00:00:008-KStáhnout
2017-02-28 00:00:0010-KStáhnout
2017-02-27 23:00:008-KStáhnout
2017-02-27 23:00:0010-KStáhnout
2017-01-10 00:00:008-KStáhnout
2017-01-09 23:00:008-KStáhnout
2017-01-09 00:00:008-KStáhnout
2017-01-08 23:00:008-KStáhnout
2017-01-05 00:00:008-KStáhnout
2017-01-04 23:00:008-KStáhnout
2016-12-19 00:00:008-KStáhnout
2016-12-18 23:00:008-KStáhnout
2016-11-07 00:00:008-KStáhnout
2016-11-07 00:00:0010-QStáhnout
2016-11-06 23:00:008-KStáhnout
2016-11-06 23:00:0010-QStáhnout
2016-09-01 01:00:008-KStáhnout
2016-09-01 00:00:008-KStáhnout
2016-08-09 01:00:008-KStáhnout
2016-08-09 01:00:0010-QStáhnout
2016-08-09 00:00:008-KStáhnout
2016-08-09 00:00:0010-QStáhnout
2016-06-08 01:00:008-KStáhnout
2016-06-08 00:00:008-KStáhnout
2016-05-09 01:00:008-KStáhnout
2016-05-09 01:00:0010-QStáhnout
2016-05-09 00:00:008-KStáhnout
2016-05-09 00:00:0010-QStáhnout
2016-05-06 01:00:008-KStáhnout
2016-05-06 00:00:008-KStáhnout
2016-03-07 00:00:008-KStáhnout
2016-03-06 23:00:008-KStáhnout
2016-02-29 00:00:008-KStáhnout
2016-02-29 00:00:0010-KStáhnout
2016-02-28 23:00:008-KStáhnout
2016-02-28 23:00:0010-KStáhnout
2016-01-26 00:00:008-KStáhnout
2016-01-25 23:00:008-KStáhnout
2016-01-13 00:00:008-KStáhnout
2016-01-12 23:00:008-KStáhnout
2016-01-11 00:00:008-KStáhnout
2016-01-10 23:00:008-KStáhnout
2016-01-04 00:00:008-KStáhnout
2016-01-03 23:00:008-KStáhnout
2015-11-09 00:00:008-KStáhnout
2015-11-09 00:00:0010-QStáhnout
2015-11-08 23:00:008-KStáhnout
2015-11-08 23:00:0010-QStáhnout
2015-08-10 01:00:008-KStáhnout
2015-08-10 01:00:0010-QStáhnout
2015-08-10 00:00:008-KStáhnout
2015-08-10 00:00:0010-QStáhnout
2015-08-06 01:00:008-KStáhnout
2015-08-06 00:00:008-KStáhnout
2015-06-05 01:00:008-KStáhnout
2015-06-05 00:00:008-KStáhnout
2015-05-11 01:00:008-KStáhnout
2015-05-11 01:00:0010-QStáhnout
2015-05-11 00:00:008-KStáhnout
2015-05-11 00:00:0010-QStáhnout
2015-03-02 00:00:008-KStáhnout
2015-03-02 00:00:0010-KStáhnout
2015-03-01 23:00:008-KStáhnout
2015-03-01 23:00:0010-KStáhnout
2015-01-26 00:00:008-KStáhnout
2015-01-25 23:00:008-KStáhnout
2015-01-21 00:00:008-KStáhnout
2015-01-20 23:00:008-KStáhnout
2015-01-12 00:00:008-KStáhnout
2015-01-11 23:00:008-KStáhnout
2015-01-07 00:00:008-KStáhnout
2015-01-06 23:00:008-KStáhnout
2014-11-10 00:00:008-KStáhnout
2014-11-10 00:00:0010-QStáhnout
2014-11-09 23:00:008-KStáhnout
2014-11-09 23:00:0010-QStáhnout
2014-10-24 01:00:008-KStáhnout
2014-10-24 00:00:008-KStáhnout
2014-08-11 01:00:008-KStáhnout
2014-08-11 01:00:0010-QStáhnout
2014-08-11 00:00:008-KStáhnout
2014-08-11 00:00:0010-QStáhnout
2014-05-16 01:00:008-KStáhnout
2014-05-16 00:00:008-KStáhnout
2014-05-12 01:00:008-KStáhnout
2014-05-12 01:00:0010-QStáhnout
2014-05-12 00:00:008-KStáhnout
2014-05-12 00:00:0010-QStáhnout
2014-04-03 01:00:008-KStáhnout
2014-04-03 00:00:008-KStáhnout
2014-02-28 00:00:0010-KStáhnout
2014-02-27 23:00:0010-KStáhnout
2014-02-27 00:00:008-KStáhnout
2014-02-26 23:00:008-KStáhnout
2014-02-05 00:00:008-KStáhnout
2014-02-04 23:00:008-KStáhnout
2014-01-13 00:00:008-KStáhnout
2014-01-12 23:00:008-KStáhnout
2014-01-03 00:00:008-KStáhnout
2014-01-02 23:00:008-KStáhnout
2013-12-18 00:00:008-KStáhnout
2013-12-17 23:00:008-KStáhnout
2013-11-08 00:00:008-KStáhnout
2013-11-08 00:00:0010-QStáhnout
2013-11-07 23:00:008-KStáhnout
2013-11-07 23:00:0010-QStáhnout
2013-10-31 00:00:008-KStáhnout
2013-10-30 23:00:008-KStáhnout
2013-08-07 01:00:008-KStáhnout
2013-08-07 01:00:0010-QStáhnout
2013-08-07 00:00:008-KStáhnout
2013-08-07 00:00:0010-QStáhnout
2013-07-03 01:00:008-KStáhnout
2013-07-03 00:00:008-KStáhnout
2013-05-24 01:00:008-KStáhnout
2013-05-24 00:00:008-KStáhnout
2013-05-17 01:00:008-KStáhnout
2013-05-17 00:00:008-KStáhnout
2013-05-08 01:00:008-KStáhnout
2013-05-08 01:00:0010-QStáhnout
2013-05-08 00:00:008-KStáhnout
2013-05-08 00:00:0010-QStáhnout
2013-03-28 00:00:008-KStáhnout
2013-03-27 23:00:008-KStáhnout
2013-03-01 00:00:0010-KStáhnout
2013-02-28 23:00:0010-KStáhnout
2013-02-25 00:00:008-KStáhnout
2013-02-24 23:00:008-KStáhnout
2013-01-07 00:00:008-KStáhnout
2013-01-06 23:00:008-KStáhnout
2013-01-04 00:00:008-KStáhnout
2013-01-03 23:00:008-KStáhnout
2012-12-05 00:00:008-KStáhnout
2012-12-04 23:00:008-KStáhnout
2012-11-08 00:00:008-KStáhnout
2012-11-08 00:00:0010-QStáhnout
2012-11-07 23:00:008-KStáhnout
2012-11-07 23:00:0010-QStáhnout
2012-10-02 01:00:008-KStáhnout
2012-10-02 00:00:008-KStáhnout
2012-08-09 01:00:0010-QStáhnout
2012-08-09 00:00:0010-QStáhnout
2012-08-06 01:00:008-KStáhnout
2012-08-06 00:00:008-KStáhnout
2012-05-07 01:00:008-KStáhnout
2012-05-07 01:00:0010-QStáhnout
2012-05-07 00:00:008-KStáhnout
2012-05-07 00:00:0010-QStáhnout
2012-03-12 00:00:0010-KStáhnout
2012-03-11 23:00:0010-KStáhnout
2012-03-09 00:00:008-KStáhnout
2012-03-08 23:00:008-KStáhnout
2012-02-10 00:00:008-KStáhnout
2012-02-09 23:00:008-KStáhnout
2012-01-09 00:00:008-KStáhnout
2012-01-08 23:00:008-KStáhnout
2011-12-12 00:00:008-KStáhnout
2011-12-11 23:00:008-KStáhnout
2011-11-08 00:00:0010-QStáhnout
2011-11-07 23:00:0010-QStáhnout
2011-11-07 00:00:008-KStáhnout
2011-11-06 23:00:008-KStáhnout
2011-08-05 01:00:008-KStáhnout
2011-08-05 01:00:0010-QStáhnout
2011-08-05 00:00:008-KStáhnout
2011-08-05 00:00:0010-QStáhnout
2011-06-16 01:00:008-KStáhnout
2011-06-16 00:00:008-KStáhnout
2011-05-11 01:00:008-KStáhnout
2011-05-11 00:00:008-KStáhnout
2011-05-06 01:00:008-KStáhnout
2011-05-06 01:00:0010-QStáhnout
2011-05-06 00:00:008-KStáhnout
2011-05-06 00:00:0010-QStáhnout
2011-03-11 00:00:008-KStáhnout
2011-03-11 00:00:0010-KStáhnout
2011-03-10 23:00:008-KStáhnout
2011-03-10 23:00:0010-KStáhnout
2011-03-08 00:00:008-KStáhnout
2011-03-07 23:00:008-KStáhnout
2011-01-10 00:00:008-KStáhnout
2011-01-09 23:00:008-KStáhnout
2010-12-08 00:00:008-KStáhnout
2010-12-07 23:00:008-KStáhnout
2010-11-05 00:00:008-KStáhnout
2010-11-05 00:00:0010-QStáhnout
2010-11-04 23:00:008-KStáhnout
2010-11-04 23:00:0010-QStáhnout
2010-10-14 01:00:008-KStáhnout
2010-10-14 00:00:008-KStáhnout
2010-09-09 01:00:008-KStáhnout
2010-09-09 00:00:008-KStáhnout
2010-08-31 01:00:008-KStáhnout
2010-08-31 00:00:008-KStáhnout
2010-08-06 01:00:008-KStáhnout
2010-08-06 01:00:0010-QStáhnout
2010-08-06 00:00:008-KStáhnout
2010-08-06 00:00:0010-QStáhnout
2010-05-20 01:00:008-KStáhnout
2010-05-20 00:00:008-KStáhnout
2010-05-07 01:00:008-KStáhnout
2010-05-07 01:00:0010-QStáhnout
2010-05-07 00:00:008-KStáhnout
2010-05-07 00:00:0010-QStáhnout
2010-03-12 00:00:008-KStáhnout
2010-03-12 00:00:0010-KStáhnout
2010-03-11 23:00:008-KStáhnout
2010-03-11 23:00:0010-KStáhnout
2010-03-03 00:00:008-KStáhnout
2010-03-02 23:00:008-KStáhnout
2010-02-09 00:00:008-KStáhnout
2010-02-08 23:00:008-KStáhnout
2010-01-11 00:00:008-KStáhnout
2010-01-10 23:00:008-KStáhnout
2009-11-06 00:00:008-KStáhnout
2009-11-06 00:00:0010-QStáhnout
2009-11-05 23:00:008-KStáhnout
2009-11-05 23:00:0010-QStáhnout
2009-10-02 01:00:008-KStáhnout
2009-10-02 00:00:008-KStáhnout
2009-08-07 01:00:008-KStáhnout
2009-08-07 01:00:0010-QStáhnout
2009-08-07 00:00:008-KStáhnout
2009-08-07 00:00:0010-QStáhnout
2009-06-23 01:00:008-KStáhnout
2009-06-23 00:00:008-KStáhnout
2009-06-17 01:00:008-KStáhnout
2009-06-17 00:00:008-KStáhnout
2009-05-08 01:00:008-KStáhnout
2009-05-08 01:00:0010-QStáhnout
2009-05-08 00:00:008-KStáhnout
2009-05-08 00:00:0010-QStáhnout
2009-04-15 01:00:008-KStáhnout
2009-04-15 00:00:008-KStáhnout
2009-03-13 00:00:008-KStáhnout
2009-03-13 00:00:0010-KStáhnout
2009-03-12 23:00:008-KStáhnout
2009-03-12 23:00:0010-KStáhnout
2009-02-09 00:00:008-KStáhnout
2009-02-08 23:00:008-KStáhnout
2009-01-26 00:00:008-KStáhnout
2009-01-25 23:00:008-KStáhnout
2009-01-09 00:00:008-KStáhnout
2009-01-08 23:00:008-KStáhnout
2008-11-07 00:00:008-KStáhnout
2008-11-07 00:00:0010-QStáhnout
2008-11-06 23:00:008-KStáhnout
2008-11-06 23:00:0010-QStáhnout
2008-11-06 00:00:008-KStáhnout
2008-11-05 23:00:008-KStáhnout
2008-08-21 01:00:008-KStáhnout
2008-08-21 00:00:008-KStáhnout
2008-08-08 01:00:008-KStáhnout
2008-08-08 01:00:0010-QStáhnout
2008-08-08 00:00:008-KStáhnout
2008-08-08 00:00:0010-QStáhnout
2008-05-15 01:00:008-KStáhnout
2008-05-15 00:00:008-KStáhnout
2008-05-09 01:00:008-KStáhnout
2008-05-09 01:00:0010-QStáhnout
2008-05-09 00:00:008-KStáhnout
2008-05-09 00:00:0010-QStáhnout
2008-04-21 01:00:008-KStáhnout
2008-04-21 00:00:008-KStáhnout
2008-03-19 00:00:008-KStáhnout
2008-03-18 23:00:008-KStáhnout
2008-03-17 00:00:008-KStáhnout
2008-03-16 23:00:008-KStáhnout
2008-03-14 00:00:0010-KStáhnout
2008-03-13 23:00:0010-KStáhnout
2008-02-12 00:00:008-KStáhnout
2008-02-11 23:00:008-KStáhnout
2008-02-08 00:00:008-KStáhnout
2008-02-07 23:00:008-KStáhnout
2007-12-20 00:00:008-KStáhnout
2007-12-19 23:00:008-KStáhnout
2007-11-20 00:00:008-KStáhnout
2007-11-19 23:00:008-KStáhnout
2007-11-14 00:00:008-KStáhnout
2007-11-13 23:00:008-KStáhnout
2007-11-09 00:00:008-KStáhnout
2007-11-09 00:00:0010-QStáhnout
2007-11-08 23:00:008-KStáhnout
2007-11-08 23:00:0010-QStáhnout
2007-09-12 01:00:008-KStáhnout
2007-09-12 00:00:008-KStáhnout
2007-08-10 01:00:008-KStáhnout
2007-08-10 00:00:008-KStáhnout
2007-08-09 01:00:0010-QStáhnout
2007-08-09 00:00:0010-QStáhnout
2007-07-31 01:00:008-KStáhnout
2007-07-31 00:00:008-KStáhnout
2007-07-09 01:00:008-KStáhnout
2007-07-09 00:00:008-KStáhnout
preloader